No organ or donor sourcing
MedTransplant does not recruit donors, locate organs, arrange donor payments, or connect patients to unverified intermediaries. Human organs must never be treated as commodities.
No allocation influence
We cannot secure priority, accelerate waiting-list access, or influence a national or regional allocation system. Deceased-donor pathways remain governed by authorized bodies and clinical rules.
Donor and recipient welfare
Living donation requires voluntary informed consent, independent donor assessment, appropriate authorization, and protection from pressure or financial inducement. Recipient safety never justifies compromising donor safety.
Transparent limitations
We identify what is known, what requires verification, and what only a clinical team or regulator can answer. Commercial relationships must never change the safety standard or editorial conclusion.